High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19
Status:
Recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the tolerability of high dose hydroxychloroquine in patients with
COVID-19 who are not yet hospitalized, but have risk factors for disease progression and
complications.